Australia markets closed

Pure Biologics S.A. (PQB.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.4380-0.0160 (-1.10%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
69
95
662
254
572
-
Cost of revenue
1,752
2,669
6,069
4,281
4,508
-
Gross profit
-1,683
-2,574
-5,407
-4,027
-3,936
-
Operating expenses
Research development
-
-
-
-
18,386
12,243
Selling general and administrative
5,713
6,539
4,511
3,797
6,014
-
Total operating expenses
26,383
27,236
19,274
6,460
7,620
-
Operating income or loss
-28,066
-29,810
-24,681
-10,487
-11,556
-
Interest expense
3,292
3,833
329
227
349
-
Income before tax
-33,627
-35,694
-25,603
-11,765
-11,756
-
Income tax expense
-
0
0
0
-
0
Income from continuing operations
-33,627
-35,694
-25,603
-11,765
-11,756
-
Net income
-33,620
-35,694
-25,603
-11,765
-11,756
-
Net income available to common shareholders
-33,620
-35,694
-25,603
-11,765
-11,756
-
Basic EPS
-11.10
-11.19
-11.36
-5.30
-7.11
-
Diluted EPS
-11.10
-11.19
-11.36
-5.30
-7.11
-
Basic average shares
2,907
3,189
2,254
2,221
1,654
-
Diluted average shares
2,940
3,288
2,254
2,254
1,682
-